Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-005187·ACHIEVE LIFE SCIENCES, INC.
Schedule 13G ownership disclosure
Achieve Life Sciences Inc
Common Stock, par value $0.001 per share · CUSIP: 004468500
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Alyeska Investment Group, L.P.
Shares: 2,982,722.00 · Class: 5.6%
- Alyeska Fund GP, LLC
Shares: 2,982,722.00 · Class: 5.6%
- Anand Parekh
Shares: 2,982,722.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-005187
- Form type
- SCHEDULE 13G/A
- Filer
- ACHIEVE LIFE SCIENCES, INC.
- CIK
- CIK 949858
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership